GATAD2A
Transcriptional repressor p66-alpha
Also known as: P66A_HUMAN, p66alpha
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86YP4
- Gene
- GATAD2A
- Ensembl
- ENSG00000167491
- Chromosome
- 19
- Canonical length
- 633 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
Enables protein-macromolecule adaptor activity. Involved in chromatin remodeling and negative regulation of DNA-templated transcription. Located in nucleoplasm. Part of NuRD complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
633 residues, UniProt reviewed canonical sequence.
>Q86YP4|GATAD2A
1 MTEEACRTRS QKRALERDPT EDDVESKKIK MERGLLASDL NTDGDMRVTP EPGAGPTQGL
61 LRATEATAMA MGRGEGLVGD GPVDMRTSHS DMKSERRPPS PDVIVLSDNE QPSSPRVNGL
121 TTVALKETST EALMKSSPEE RERMIKQLKE ELRLEEAKLV LLKKLRQSQI QKEATAQKPT
181 GSVGSTVTTP PPLVRGTQNI PAGKPSLQTS SARMPGSVIP PPLVRGGQQA SSKLGPQASS
241 QVVMPPLVRG AQQIHSIRQH SSTGPPPLLL APRASVPSVQ IQGQRIIQQG LIRVANVPNT
301 SLLVNIPQPT PASLKGTTAT SAQANSTPTS VASVVTSAES PASRQAAAKL ALRKQLEKTL
361 LEIPPPKPPA PEMNFLPSAA NNEFIYLVGL EEVVQNLLET QGRMSAATVL SREPYMCAQC
421 KTDFTCRWRE EKSGAIMCEN CMTTNQKKAL KVEHTSRLKA AFVKALQQEQ EIEQRLLQQG
481 TAPAQAKAEP TAAPHPVLKQ VIKPRRKLAF RSGEARDWSN GAVLQASSQL SRGSATTPRG
541 VLHTFSPSPK LQNSASATAL VSRTGRHSER TVSAGKGSAT SNWKKTPLST GGTLAFVSPS
601 LAVHKSSSAV DRQREYLLDM IPPRSIPQSA TWKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GATAD2A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 31 nTPM
- testis: 31 nTPM
- small intestine: 23 nTPM
- appendix: 22 nTPM
- duodenum: 21 nTPM
- spleen: 21 nTPM
Single-cell type
- neutrophils: 616 nCPM
- neutrophil progenitors: 255 nCPM
- endometrial glandular cells: 236 nCPM
- sertoli cells: 222 nCPM
- nk-cells: 199 nCPM
- suprabasal keratinocytes: 196 nCPM
Immune cell
- neutrophil: 7.7 nTPM
- basophil: 4.7 nTPM
- non-classical monocyte: 3.3 nTPM
- eosinophil: 3.2 nTPM
- gdT-cell: 3.2 nTPM
- plasmacytoid DC: 3 nTPM
Brain region
- medulla oblongata: 38 nTPM
- choroid plexus: 38 nTPM
- hippocampal formation: 34 nTPM
- thalamus: 34 nTPM
- pons: 32 nTPM
- midbrain: 32 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GATAD2A.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 135 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- GATAD2A-associated neurodevelopmental disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.2
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.27
- DepMap mean gene effect
- -0.32
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin remodeling
- negative regulation of DNA-templated transcription
- negative regulation of transcription by RNA polymerase II
- positive regulation of DNA-templated transcription
- regulation of cell fate specification
- regulation of stem cell differentiation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GATAD2A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GATAD2A as an antibody target. Whether an autoantibody or antibody against GATAD2A could matter depends on whether native GATAD2A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GATAD2A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GATAD2A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...